BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)

Giuseppe Montalto, Céline Loncle, Audrey Benyamine, Véronique Secq, Anne-Sophie Chrétien, Céline Castanier, Etienne Foucher, Elena Vila-Navarro, Juan-Luis Blazquez, Mauro Modesti, Etienne Foucher, Meritxell Gironella, Nelson Dusetti, Jean-Charles Dagorn, Salem Chouaib, Juan Iovanna, Daniel Olive

Risultato della ricerca: Articlepeer review

18 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)'. Insieme formano una fingerprint unica.

Medicine & Life Sciences